Healthy subjects
Conditions
Interventions
On the day intake of the test food Wash out On the day intake of the placebo
On the day intake of the placebo Wash out On the day intake of the test food
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Subjects giving written informed consent. 2.Japanese males and females aged 30-59 years. 3.Non-smokers.
Exclusion criteria
Exclusion criteria: 1.Subjects currently in treatment with medication or seeing a doctor for treatment. 2. Subjects having a history of a drug allergy and/or food allergy. 3.Subjects being pregnant or nursing, or desired to become pregnant during the study. 4.Subjects being patient or having a history of severe brain disorder. 5.Subjects being vaccinated within the last three months or desired to be vaccinated during a study period. 6.Subjects having regular intake of a health foods or supplements with a possible effect on improved concentration. 7.Subjects being patient or having a history of psychiatric visits for depression, sleep disorder, etc. 8.Subjects having extremely irregular lifestyle such as a dietary pattern and a sleeping pattern. 9.Subjects participated in another clinical trial in the last three months. 10.Subjects determined by the investigator to be unsuitable for enrollment in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Cognitrax 2.Uchida-Kraepelin Test | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.POMS2 (Brief edition) 2.VAS | — |
Countries
Japan
Contacts
Public ContactOchitani Daisuke
HUMA R&D CORP Clinical Development Division
Outcome results
None listed